Suyoung Kim

Suyoung Kim

Auto-generated profile, based on publicly available information

Suyoung Kim

Department of Laboratory Medicine Health Promotion Research Institute Korea Association of Health Promotion Seoul Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
ENEun-Hee Nah
Eun-Hee Nah
SCSeon Cho
Seon Cho
SKSuyoung Kim
Suyoung Kim
HCHan Ik Cho
Han Ik Cho
Eun-Hee Nah, M.D., Seon Cho, M.S., Suyoung Kim, M.S., and Han-Ik Cho, M.D.. Ann Lab Med 2017;37:426-33. https://doi.org/10.3343/alm.2017.37.5.426

29 March 2020 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
ENEun-Hee Nah
Eun-Hee Nah
SCSeon Cho
Seon Cho
SKSuyoung Kim
Suyoung Kim
HKHye‐Sun Kim
Hye‐Sun Kim
HCHan‐Ik Cho
Han‐Ik Cho
Background: Mild‐to‐moderate fibrosis is rarely diagnosed because the disease is asymptomatic in the early stage. The serum level of Mac‐2 binding protein glycosylation isomer (M2BPGi) has been found to increase with the severity of liver fibrosis. The aim of this study was to determine the diagnostic performance of M2BPGi in screening liver fibrosis using magnetic resonance elastography (MRE) as a reference standard and to compare it with using the aspartate aminotransferase‐to‐platelet ratio (APRI) and the Fibrosis‐4 index (FIB‐4) in health checkups. Methods: This cross‐sectional study consecutively selected subjects at health examinations who underwent MRE and M2BPGi testing at eight health promotion centers in Korea between January and September 2019. The serum M2BPGi level was measured using the chemiluminescence enzyme immunoassay method. The measured levels were indexed using the cutoff index (COI). COI values of M2BPGi were compared with the MRE results. Results: The median (interquartile) values of COI for fibrosis stages F0 (normal liver stiffness), F1 (mild fibrosis), F2 (significant fibrosis), and ≥F3 (advanced fibrosis) were 0.49 (0.34‐0.61), 0.48 (0.38‐0.68), 0.64 (0.43‐1.03), and 1.01 (0.75‐1.77), respectively ( P < .0001). The AUCs of the COI for the screening of fibrosis stage ≥F1, ≥F2, and ≥F3 were 0.591, 0.698, and 0.853, respectively. Using a threshold of 0.75 for COI to exclude advanced fibrosis had a sensitivity, specificity, and negative predictive value of 80.0%, 77.9%, and 98.9%, respectively. The AUC for excluding advanced fibrosis was better for M2BPGi than for FIB‐4 and APRI. Conclusion: Serum M2BPGi was useful for screening significant and advanced fibrosis in health checkups.

12 February 2020 in International Journal of Laboratory Hematology
Verified
Journal Article
Closed access
PDF file
ENEun-Hee Nah
Eun-Hee Nah
SCSeon Cho
Seon Cho
SKSuyoung Kim
Suyoung Kim
JCJieun Chu
Jieun Chu
EKEunjoo Kwon
Eunjoo Kwon
HCHan‐Ik Cho
Han‐Ik Cho

31 August 2020 in Epidemiology and Health
Verified
Journal Article
Open access
PDF file
SKSuyoung Kim
Suyoung Kim
SCSeon Cho
Seon Cho
ENEun-Hee Nah
Eun-Hee Nah
OBJECTIVES: This study aimed to identify latent classes in hypertensive patients based on the clustering of factors including lifestyle risk factors, metabolic risk factors, and obesity in each sex. METHODS: This cross-sectional study included 102,780 male and 103,710 female hypertensive patients who underwent health check-ups at 16 centers in Korea, in 2018. A latent class analysis approach was used to identify subgroups of hypertensive patients. Multinomial logistic regression was performed to examine the association between latent classes and comorbidities of hypertension. RESULTS: A four-class model provided the best fit for each sex. The following latent classes were identified: Class I (male: 16.9%, female: 1.7%; high risk of lifestyle behaviors [HB] with metabolic disorders and obesity [MO]), Class II (male: 32.4%, female: 47.1%; low risk of lifestyle behaviors [LB] with MO), Class III (male: 15.3%, female: 1.8%; HB with metabolic disorders and normal weight [MNW]), Class W (male: 35.5%, female: 49.4%; LB with MNW). Lifestyle patterns in the latent classes were classified as high-risk or low-risk according to smoking and high-risk drinking among male, and presented complex patterns including physical inactivity alone or in combination with other factors, among female. Stage 2 hypertensive or diabetic individuals were likely to belong to classes including obesity (HB-MO, LB-MO) in both sexes, and additionally belonged to the HB-MNW class in male. CONCLUSIONS: Metabolic disorders were included in all latent classes, with or without lifestyle risk factors and obesity. Hypertensive females need to manage obesity, and hypertensive males need to manage lifestyle risk factors and obesity. Sex-specific lifestyle behaviors are important for controlling hypertension.

7 July 2020 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
ENEun-Hee Nah
Eun-Hee Nah
SCSeon Cho
Seon Cho
SKSuyoung Kim
Suyoung Kim
HCHan‐Ik Cho
Han‐Ik Cho
Background: Soluble ST2 (sST2) is known to predict adverse outcomes and death in individuals with established heart failure. However, the role of sST2 testing in the general population has not been established. The aims of this study were to determine the reference interval (RI) and the clinical utility of sST2 in subclinical cardiac dysfunction in general population.Methods: This cross‐sectional study consecutively selected 41,806 general subjects at health checkups who underwent echocardiography and sST2 testing at 16 health promotion centers in 13 Korean cities. The reference subjects were obtained among those with normal findings in echocardiography. Sex‐specific RIs were established according to the CLSI C28‐A3 guidelines. sST2 was measured using immunoassay with the Presage ST2 assay (Critical Diagnostics).Results: In the general subjects, age, sex, BMI, systolic blood pressure, blood glucose, creatinine, liver function, and triglycerides were associated with the sST2 levels. The RI for sST2 was higher in males (≤49.6 ng/mL, 95% CI = 48.5‐51.5) than in females (≤44.5 ng/mL, 95% CI = 43.5‐45.6) and higher in subjects aged < 40 years than ≥ 40 years in both sexes. The sST2 levels were 29.1 ± 10.7 (mean ± SD) and 29.1 ± 14.4 ng/mL in the groups with normal cardiac function and subclinical cardiac dysfunction, respectively. The sST2 level was not associated with subclinical cardiac dysfunction (odd ratio = 1.002, P = .13).Conclusions: RIs obtained from a large and echocardiography‐proven healthy community‐based sample are presented. Subclinical cardiac dysfunction was associated with older age, male sex, and metabolic factors but not with the sST2 level.

1 January 2019 in Korean Journal of Health Promotion
Verified
Journal Article
Open access
PDF file
EKEunjoo Kwon
Eunjoo Kwon
ENEun-Hee Nah
Eun-Hee Nah
SCSeon Cho
Seon Cho
JCJieun Chu
Jieun Chu
SKSuyoung Kim
Suyoung Kim
Kwon E, et al. Korean J Health Promot. 2019 Dec;19(4):221-228. https://doi.org/10.15384/kjhp.2019.19.4.221